Tag: cell therapy market statistics

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Cell Therapy Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The cell therapy market has expanded significantly in recent years. It is forecast to rise from $16.87 billion in 2025 to $19.31 billion in 2026, registering a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be linked to the considerable expense of autologous therapies, difficulties in donor availability, the absence of standardized manufacturing, successful early-stage clinical trials, and the growing occurrence of chronic diseases.

The cell therapy market is projected for substantial expansion over the coming years. It is anticipated to reach a valuation of $32.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This projected increase during the forecast period stems from factors such as progress in gene editing, automation within cell manufacturing processes, increased funding for cell therapy startups, a rising need for regenerative medicine, and broader applications in oncology and cardiovascular disease (CVD). Key developments expected within this period encompass the evolution of personalized cell therapies, breakthroughs in allogeneic therapies, enhancements in cell storage and transportation, innovations in regulatory frameworks and compliance, and the emergence of new clinical uses.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=95938037&type=smp&name=Cell%20Therapy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Cell Therapy Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The increasing occurrence of chronic illnesses fueled the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term condition, persisting for at least one year, necessitating medical care, restricting daily functions, or both, encompassing ailments such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells hold potential benefits for individuals with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. Notably, in July 2024, the Centers for Disease Control and Prevention (CDC), a U.S. national public health body, issued key updates concerning public health efforts. Annually, more than 944,800 Americans succumb to heart disease or stroke, which represents over one-third of all fatalities. Each year in the U.S., 1.7 million individuals receive a cancer diagnosis, resulting in over 600,000 deaths, positioning it as the second leading cause of mortality. Furthermore, diabetes affects over 38 million Americans, with an additional 98 million adults categorized as prediabetic, elevating their susceptibility to type 2 diabetes. Serious complications such as heart disease, kidney failure, and blindness can arise from diabetes. Obesity impacts 20% of children and 42% of adults, thereby increasing the likelihood of chronic conditions like type 2 diabetes, heart disease, and specific cancers. This escalating prevalence of chronic diseases has boosted the demand for cell therapies, consequently fostering the growth of the cell therapy market.

Cell Therapy Market Segments: Where Is Growth Concentrated?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Cell Therapy Market Innovation Trends Shaping Future Development

Leading companies within the cell therapy market are innovating next-generation, multi-targeted treatments, backed by robust early-stage clinical findings, aiming to boost therapeutic efficacy and address significant unmet needs in challenging cancers. An illustrative case is Johnson & Johnson, a pharmaceutical firm based in the US, which in June 2025, disclosed promising preliminary outcomes from its Phase 1b investigation of JNJ-4496. This particular therapy is a dual-targeting CAR T-cell approach engineered to engage both CD19 and CD20 for patients with relapsed or refractory large B-cell lymphoma. Initial data, unveiled at the 2025 EHA Congress, indicated impressive response rates, showing 75–80% complete responses at the recommended Phase 2 dose, critically without any Grade 3–4 cytokine release syndrome. The treatment demonstrated encouraging safety, manageable neurotoxicity, and potent activity even in individuals who had undergone extensive prior treatments. These discoveries underscore the promise of advanced dual-targeting CAR T strategies and reaffirm Johnson & Johnson’s commitment to advancing breakthrough treatments for B-cell malignancies.

Cell Therapy Market Key Participants And Competitive Landscape

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

View The Full Cell Therapy Market Report:

https://thebusinessresearchcompany.com/report/Cells-Therapy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Cell Therapy Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cell Therapy Market Forecast Highlighting Growth From $19.31 Billion To $32.47 Billion

The cell therapy market has seen substantial expansion in recent years. This market is projected to increase from $16.87 billion in 2025 to $19.31 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.5%. Key drivers behind this historical growth include the elevated expense of autologous treatments, scarce donor resources, the absence of uniform manufacturing processes, promising results from early-phase clinical trials, and a growing occurrence of chronic illnesses.

The cell therapy market is projected to experience substantial expansion over the coming years, reaching a valuation of $32.48 billion by 2030, driven by a compound annual growth rate of 13.9 percent. Several factors are fueling this anticipated growth, including progress in gene editing, the automation of cell production processes, increased funding for cell therapy startups, a rising need for regenerative medicine, and the broadening of applications into oncology and cardiovascular disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Cell Therapy Market Growth Factors Supporting Long-Term Expansion

The expansion of the cell therapy market has been driven by the increasing incidence of chronic diseases. As defined by the US Centers for Disease Control and Prevention (CDC), these are conditions persisting for a year or longer, necessitating ongoing medical care, limiting daily activities, or both—encompassing ailments like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cell treatments offer potential benefits for patients with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the CDC—a US-based national public health agency—announced important updates in public health initiatives. Every year, heart disease or stroke claims over 944,800 American lives, representing more than a third of all deaths nationwide. Cancer is diagnosed in 1.7 million people annually in the U.S., with over 600,000 deaths, positioning it as the second most common cause of mortality. Furthermore, more than 38 million Americans live with diabetes, while an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. This condition can lead to severe outcomes such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, further raising the risk for chronic issues like type 2 diabetes, heart disease, and certain cancers. This growing burden of chronic diseases has spurred demand for cell therapies, thereby fueling growth in the cell therapy market.

Cell Therapy Market Segment Landscape: Which Areas Lead Market Development?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Cell Therapy Market Industry Trends Shaping Future Revenue Growth

Major players in the cell therapy sector are advancing next-generation, multi-targeted treatments backed by promising early-stage clinical data, aiming to boost therapeutic efficacy and address unmet needs in complex cancers. For example, in June 2025, Johnson & Johnson, a US pharmaceutical giant, unveiled encouraging first results from its Phase 1b trial of JNJ-4496—a dual-targeting CAR T-cell therapy that binds both CD19 and CD20 for relapsed or refractory large B-cell lymphoma. Initial data presented at the 2025 EHA Congress indicated robust response rates, achieving 75–80% complete responses at the recommended Phase 2 dose with no Grade 3–4 cytokine release syndrome reported. The regimen showed a favorable safety profile, manageable neurotoxicity, and meaningful activity even in heavily pretreated patients. These outcomes underscore the promise of next-generation dual-targeting CAR T strategies and reaffirm Johnson & Johnson’s dedication to pioneering novel therapies for B-cell malignancies.

Cell Therapy Market Industry Leaders And Market Competition

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Access The Complete Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Cell Therapy Market Largest Region By Revenue And Market Share

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Cell Therapy Market By 2030 Based On Its 2026 Value?

The cell therapy market size has seen rapid expansion in recent years. This market is forecast to expand from $16.87 billion in 2025 to $19.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be attributed to the high cost associated with autologous therapies, constraints in donor availability, the absence of standardized manufacturing processes, early successes in clinical trials, and an increasing incidence of chronic diseases.

The cell therapy market is projected to experience substantial expansion in the upcoming years, with its valuation expected to reach $32.48 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This predicted rise over the forecast period is primarily driven by advances in gene editing techniques, increased automation in cell manufacturing, a surge in investments directed towards cell therapy startups, the rising demand for regenerative medicine solutions, and the broadening application of these therapies across oncology and cardiovascular diseases. Significant trends during this period are anticipated to include the development of personalized cell therapies, advancements in allogeneic therapies, improvements in cell storage and transportation methods, innovations in regulatory and compliance protocols, and the emergence of new clinical applications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Primary Factors Are Fueling The Expansion Of The Cell Therapy Market?

The increasing occurrence of chronic illnesses supported the growth of the cell therapy sector. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term ailment, lasting a year or longer, often needing medical care, restricting daily activities, or both, encompassing conditions such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cell applications offer advantages for individuals afflicted with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, issued important updates concerning public health programs. Annually, more than 944,800 Americans succumb to heart disease or stroke, making up over one-third of all fatalities. In the U.S., 1.7 million people are diagnosed with cancer each year, with over 600,000 deaths, positioning it as the second principal cause of mortality. Furthermore, over 38 million Americans suffer from diabetes, and an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. Diabetes has the potential to result in serious complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, intensifying the likelihood of chronic conditions including type 2 diabetes, heart disease, and specific cancers. The expanding occurrence of chronic illnesses boosted the need for cell therapies and supported the development of the cell therapy market.

What Are The Major Segment Categories Within The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Trends Are Influencing The Future Of The Cell Therapy Market?

Major companies within the cell therapy market are engaged in the development of advanced, multi-targeted treatments, leveraging robust early-stage clinical findings to boost efficacy and address unmet medical demands in challenging cancers. An illustrative example occurred in June 2025, when Johnson & Johnson, a US-based pharmaceutical entity, disclosed encouraging preliminary outcomes from its Phase 1b investigation of JNJ-4496. This specific therapy is a dual-targeting CAR T-cell therapy engineered to attach to both CD19 and CD20, intended for individuals with relapsed or refractory large B-cell lymphoma. Initial data, unveiled at the 2025 EHA Congress, demonstrated impressive response rates, achieving 75–80% complete responses at the optimized Phase 2 dosage, alongside an absence of Grade 3–4 cytokine release syndrome. The treatment exhibited promising safety characteristics, manageable neurotoxicity, and considerable activity even among patients who had undergone extensive prior treatments. These discoveries highlight the promise inherent in future dual-targeting CAR T methodologies and reaffirm Johnson & Johnson’s commitment to pioneering innovative therapies for B-cell malignancies.

Who Are The Leading Firms Participating In The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Access The Complete Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Market Leads The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Cell Therapy Market Over The 2026–2030 Period?

The cell therapy market size has experienced rapid expansion in recent years. It is anticipated to increase from $16.87 billion in 2025 to $19.31 billion in 2026, progressing at a compound annual growth rate (CAGR) of 14.5%. The historical growth in this market can be linked to factors such as the high cost of autologous therapies, limited donor availability, the absence of standardized manufacturing, successful early-stage clinical trials, and an increasing incidence of chronic diseases.

The cell therapy market is anticipated to experience significant expansion in the coming years. It is projected to reach $32.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This growth during the forecast period stems from factors such as progress in gene editing, increased automation in cell manufacturing, rising investments in cell therapy startups, heightened demand for regenerative medicine, and broader applications in oncology and cardiovascular diseases. Key trends for this period encompass the development of personalized cell therapies, strides in allogeneic therapies, enhancements in cell storage and transportation, innovations in regulatory and compliance frameworks, and the emergence of new clinical applications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Important Drivers Are Guiding The Cell Therapy Market Growth?

The expansion of the cell therapy market was significantly aided by the increasing incidence of chronic diseases. The US Centers for Disease Control and Prevention (CDC) defines a chronic disease as a condition lasting a year or more, requiring medical attention, limiting daily activities, or both, and this category includes heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential benefits to patients suffering from conditions like spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, released significant updates concerning public health initiatives. Annually, over 944,800 Americans die from heart disease or stroke, accounting for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer each year, with over 600,000 fatalities, making it the second leading cause of death. Furthermore, more than 38 million Americans have diabetes, while an additional 98 million adults are prediabetic, raising their risk for type 2 diabetes. Diabetes can lead to severe complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby heightening the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers. Consequently, the expanding prevalence of chronic diseases has boosted the demand for cell therapies, contributing to the growth of the cell therapy market.

How Are Different Segments Classified In The Cell Therapy Market Segment Analysis?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Trends Are Shaping Growth In The Cell Therapy Market?

Leading companies within the cell therapy market are engaged in the development of advanced, multi-targeted therapeutic options, supported by robust early-stage clinical data, to enhance the effectiveness of treatments and address existing unmet medical needs in complex cancers. For example, in June 2025, Johnson & Johnson, a US-based pharmaceutical company, announced positive initial outcomes from its Phase 1b study involving JNJ-4496, a dual-targeting CAR T-cell therapy engineered to bind both CD19 and CD20 in patients with relapsed or refractory large B-cell lymphoma. Preliminary data, presented at the 2025 EHA Congress, indicated impressive response rates, achieving 75–80% complete responses at the recommended Phase 2 dose, with no instances of Grade 3–4 cytokine release syndrome. The therapy demonstrated encouraging safety, manageable neurotoxicity, and considerable activity, even in patients who had received extensive prior treatments. These findings underscore the potential of next-generation dual-targeting CAR T approaches and reinforce Johnson & Johnson’s commitment to progressing innovative therapies for B-cell malignancies.

Who Are The Companies Driving Activity In The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Get The Full Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Region Holds The Highest Market Share In The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Cell Therapy Market Across 2026–2030?

The cell therapy market has experienced substantial expansion in recent years. It is anticipated to grow from $16.87 billion in 2025 to $19.31 billion in 2026, at a compound annual growth rate (CAGR) of 14.5%. The historic period’s growth can be attributed to factors such as the high cost of autologous therapies, limited donor availability, a lack of standardized manufacturing, successful early-stage clinical trials, and the rising incidence of chronic diseases.

The cell therapy market is set for significant expansion in the coming years, with its size projected to reach $32.48 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.9%. This growth throughout the forecast period can be attributed to several factors, including advancements in gene editing, increased automation within cell manufacturing, growing investment in cell therapy startups, a surging demand for regenerative medicine, and expanding applications across oncology and cardiovascular diseases. Prominent trends for the same period are expected to include the development of personalized cell therapies, progress in allogeneic therapies, improved solutions for cell storage and transportation, innovations in regulatory frameworks and compliance, and the emergence of new clinical applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Cell Therapy Market?

The increasing occurrence of chronic illnesses supported the growth of the cell therapy market. As defined by the US Centers for Disease Control and Prevention (CDC), a chronic disease is an ailment persisting for at least a year, necessitating medical care, restricting everyday functions, or both, encompassing conditions such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential advantages for individuals affected by spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), which is a US-based national public health agency, issued important updates concerning public health efforts. Annually, more than 944,800 Americans succumb to heart disease or stroke, representing over one-third of all fatalities. Within the U.S., 1.7 million individuals receive a cancer diagnosis each year, resulting in over 600,000 fatalities, positioning it as the second primary cause of death. Furthermore, over 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. Diabetes has the potential to cause serious complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby increasing the likelihood of chronic conditions like type 2 diabetes, heart disease, and specific cancers. This escalating prevalence of chronic diseases has boosted the need for cell therapies and fueled the expansion of the cell therapy market.

What Segmentation Levels Are Considered In The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Trends Are Projected To Affect The Cell Therapy Market?

Leading companies within the cell therapy market are actively engaged in developing next-generation, multi-targeted therapies. These endeavors are supported by robust early-stage clinical data, with the goal of enhancing treatment effectiveness and addressing critical unmet needs in complex cancers. For instance, in June 2025, Johnson & Johnson, a US-based pharmaceutical company, reported encouraging initial findings from its Phase 1b study of JNJ-4496. This therapy is a dual-targeting CAR T-cell treatment designed to bind to both CD19 and CD20, intended for individuals with relapsed or refractory large B-cell lymphoma. Early data, presented at the 2025 EHA Congress, indicated strong response rates, with 75–80% complete responses observed at the recommended Phase 2 dose and no Grade 3–4 cytokine release syndrome. The therapy demonstrated promising safety, manageable neurotoxicity, and potent activity even in patients who had undergone extensive prior treatments. These outcomes underscore the significant potential of advanced dual-targeting CAR T strategies and reinforce Johnson & Johnson’s dedication to progressing innovative therapies for B-cell malignancies.

Which Leading Firms Are Contributing To The Growth Of The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Read the full cell therapy market report here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regions Are Projected To Dominate The Cell Therapy Market In The Coming Years?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cell Therapy Market between 2026 and 2030?

The cell therapy market size has witnessed substantial growth in recent years. It is projected to expand from $16.87 billion in 2025 to $19.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be ascribed to elements such as the elevated cost of autologous therapies, restricted donor availability, a deficiency in standardized manufacturing, the success of early-stage clinical trials, and the rising prevalence of chronic diseases.

The cell therapy market is poised for substantial growth over the next few years. It is projected to expand to $32.48 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.9%. This anticipated expansion during the forecast period stems from various factors, including breakthroughs in gene editing, increased automation in cell manufacturing processes, rising investments in cell therapy startups, an escalating demand for regenerative medicine, and wider applications across oncology and cvd. Significant trends during this period are expected to involve the progression of personalized cell therapy, advancements in allogeneic therapies, improvements in cell storage and transportation, innovations in regulatory and compliance frameworks, and the introduction of new clinical applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Drivers Are Expected To Impact The Cell Therapy Market During The Forecast Period?

The increasing occurrence of chronic illnesses supported the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a condition that lasts for one year or more, requires medical attention, limits daily activities, or both, and includes heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells demonstrate potential benefits for patients suffering from spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, released significant updates regarding public health initiatives. Annually, over 944,800 Americans die from heart disease or stroke, accounting for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer each year, with over 600,000 fatalities, making it the second leading cause of death. Additionally, more than 38 million Americans have diabetes, while another 98 million adults are prediabetic, which elevates their risk for type 2 diabetes. Diabetes can lead to severe complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, heightening the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers. The expanding prevalence of chronic diseases has boosted the demand for cell therapies and contributed to the growth of the cell therapy market.

How Is The Cell Therapy Market Divided Into Segments?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Trends Are Projected To Support The Growth Of The Cell Therapy Market?

Leading companies in the cell therapy market are developing advanced, multi-targeted therapies, supported by strong early-stage clinical data, to enhance treatment effectiveness and address unmet needs in complex cancers. For example, in June 2025, Johnson & Johnson, a US-based pharmaceutical entity, reported promising initial outcomes from its Phase 1b study of JNJ-4496, a dual-targeting CAR T-cell therapy designed to bind both CD19 and CD20 in individuals with relapsed or refractory large B-cell lymphoma. Early data presented at the 2025 EHA Congress revealed substantial response rates, achieving 75–80% complete responses at the recommended Phase 2 dose, with no occurrences of Grade 3–4 cytokine release syndrome. The therapy demonstrated encouraging safety profiles, manageable neurotoxicity, and robust activity even in heavily pretreated patients. These findings emphasize the potential of next-generation dual-targeting CAR T methods and strengthen Johnson & Johnson’s commitment to progressing innovative treatments for B-cell malignancies.

Which Key Players Are Driving Competition In The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Region Is Projected To Lead The Cell Therapy Market During The Forecast Period?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Cell Therapy Industry By 2029?

The cell therapy market has experienced substantial growth in its size during recent years. This market is projected to expand from $14.56 billion in 2024 to $16.87 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.8%. Historically, the expansion of the market can be attributed to initial research and discoveries, critical regulatory milestones, comprehensive clinical trials and studies, the involvement of early adopters and pioneering companies, and broader market acceptance and perception.

The cell therapy market is anticipated to experience substantial growth over the next few years, expanding to $28.67 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 14.2%. This expected expansion during the forecast period is fueled by ethical and societal factors, investment and funding patterns, consumer/patient requirements, advancements in healthcare infrastructure, and swift innovation cycles. Significant trends in the coming period involve personalized medicine, novel targeted treatments, gene editing technologies, the expansion of stem cell research, breakthroughs in immunotherapy, and methods for microenvironment manipulation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Major Drivers Are Impacting The Cell Therapy Market?

The increasing occurrence of chronic illnesses supported the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term condition, lasting a year or longer, that necessitates medical care, restricts daily life, or both, encompassing conditions such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential advantages for individuals affected by spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, published notable updates concerning public health programs. Annually, more than 944,800 Americans succumb to heart disease or stroke, representing over one-third of all fatalities. Each year in the U.S., 1.7 million individuals receive a cancer diagnosis, resulting in over 600,000 deaths, positioning it as the second leading cause of death. Furthermore, over 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. Diabetes carries the potential for serious complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby increasing the likelihood of chronic conditions like type 2 diabetes, heart disease, and specific cancers. The increasing incidence of chronic diseases has boosted the demand for cell therapies and fostered the expansion of the cell therapy market.

Which Segment Categories Are Driving Maximum Growth In The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Long-Term Trends Will Play A Crucial Role In The Cell Therapy Market?

Leading market entities are forming strategic alliances and collaborations to broaden their product range and extend their global footprint. In November 2023, Ajinomoto Co Inc., a food company headquartered in Japan, completed the acquisition of Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide proficiency in AAV and plasmid gene therapy manufacturing, thereby enriching and reinforcing its current contract development and manufacturing services. Forge Biologics is a US-based biotechnology enterprise dedicated to advancing cell therapy technologies for the treatment of diverse illnesses.

Who Are The Dominant Players In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Region Is At The Forefront Of Innovation In The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company

Flow Cytometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Cell Therapy Market By 2029?

The cell therapy market has experienced significant expansion in recent years. This market is set to increase from $14.56 billion in 2024 to $16.87 billion in 2025, showing a compound annual growth rate (CAGR) of 15.8%. Historically, the factors contributing to this growth include early research and discoveries, key regulatory milestones, extensive clinical trials and studies, the initiatives of early adopters and pioneering companies, and rising market acceptance and perception.

The cell therapy market is projected to undergo significant expansion in the coming years, with its size expected to reach $28.67 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is primarily driven by ethical and societal considerations, evolving investment and funding patterns, increasing consumer and patient demand, enhancements in healthcare infrastructure, and swift innovation cycles. Notable trends anticipated for this period encompass personalized medicine, the emergence of targeted treatments, advancements in gene editing technologies, the broadening of stem cell research, improvements in immunotherapy, and strategies for microenvironment manipulation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Cell Therapy Industry?

The increasing occurrence of chronic illnesses has significantly propelled the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a condition persisting for a year or longer, often necessitating medical intervention, limiting daily activities, or both, and encompassing ailments like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer therapeutic promise for patients with conditions such as spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a US national public health agency, released important updates regarding public health initiatives, highlighting critical statistics. Annually, over 944,800 Americans succumb to heart disease or stroke, constituting more than one-third of all fatalities. In the U.S., 1.7 million individuals are diagnosed with cancer each year, with over 600,000 fatalities, positioning it as the second leading cause of death. Furthermore, more than 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, raising their risk for type 2 diabetes. Diabetes can lead to severe health issues including heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby escalating the risk of chronic ailments like type 2 diabetes, heart disease, and specific cancers. Ultimately, the growing incidence of chronic diseases has heightened the demand for cell therapies, contributing to the overall growth of the cell therapy market.

What Are The Segment Types Shaping The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

How Are Emerging Market Trends Shaping The Cell Therapy Industry Landscape?

Leading industry participants are forming strategic alliances and engaging in collaborations to broaden their product offerings and extend their global reach. As of November 2023, Ajinomoto Co Inc., a Japanese food enterprise, completed the acquisition of Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide expertise in AAV and plasmid gene therapy production, thereby enhancing and reinforcing its current contract development and manufacturing services. Forge Biologics, an American biotechnology firm, specializes in developing innovative cell therapy technologies to address a range of illnesses.

Who Are The Primary Competitors In The Global Cell Therapy Market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Contributing Most To The Cell Therapy Industry Expansion?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company

Flow Cytometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Cell Therapy Market?

In recent times, the cell therapy market has experienced significant expansion. The market is projected to increase from a value of $14.56 billion in 2024 to $16.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. The historical development of the market can be traced back to initial research as well as breakthroughs, regulatory landmarks, clinical trials and investigations, early adopting companies, as well as the overall market receptivity and impression.

The market size for cell therapy is projected to experience swift expansion in the subsequent years, with a prediction to rise to “$28.67 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 14.2%. The escalation predicted within this forecast period can be accredited to ethics and societal aspects, investor and funding trends, customer/patient demand, healthcare facility structure, quick innovation cycles. The core trends anticipated during this period encompass personalized medicine, the advent of targeted treatments, gene alteration technologies, stem cell research broadening, advancements in immunotherapy, and the manipulation of microenvironments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Cell Therapy Market?

The escalating incidence of chronic illnesses has prompted the growth of the cell therapy market. As defined by the US Centers for Disease Control and Prevention (CDC), a chronic disease is a health condition that persists for a year or longer, requires medical intervention, restricts daily tasks, or both. This category includes ailments like heart disease, cancer, diabetes, and Parkinson’s disease. Individuals afflicted with conditions like spinal cord injuries, type 1 diabetes, Parkinson’s disease, heart disease, cancer, and osteoarthritis can derive benefits from stem cells. For instance, the US Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, released significant updates on public health initiatives in July 2024. Each year, heart disease or stroke claims the lives of over 944,800 Americans, constituting more than one-third of total deaths. In the United States, cancer is diagnosed in 1.7 million individuals annually with over 600,000 resulting in death, making it the second most common cause of death. Moreover, diabetes affects over 38 million Americans, with another 98 million adults identified as prediabetic, increasing their chances of developing type 2 diabetes. Complications from diabetes can result in serious health problems like heart disease, kidney failure, and even blindness. Obesity, which afflicts 20% of children and 42% of adults, augments risk for chronic diseases such as type 2 diabetes, heart disease, and certain types of cancer. This heightened incidence of chronic illnesses has bolstered demand for cell therapies, thereby facilitating the expansion of the cell therapy market.

Which Segmentation Categories Are Highlighted In The Cell Therapy Market Analysis?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Market Trends Are Expected To Define The Future Of The Cell Therapy Market?

Major market participants are tactically forming partnerships and collaborations to enhance their range of products and extend their presence globally. In November 2023, Ajinomoto Co Inc., a food company originating from Japan, bought Forge Biologics for a sum of $620 million. With this purchase, Ajinomoto Co Inc. seeks to strengthen its worldwide efficacy in AAV and plasmid gene therapy production, supplementing and strengthening its currently available contract development and manufacturing services. Forge Biologics is a biotechnology firm situated in the U.S., dedicated to the progress of cell therapy technologies for treating a variety of diseases.

Who Are The Dominant Players In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model